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Abstract
The remodeling capacity of microtubules (MT) is essential for their proper function. In mammals, MTs are predominantly
formed at the centrosome, but can also originate from non-centrosomal sites, a process that is still poorly understood. We
here show that the small heat shock protein HSPB1 plays a role in the control of non-centrosomal MT formation. The HSPB1
expression level regulates the balance between centrosomal and non-centrosomal MTs. The HSPB1 protein can be detected
specifically at sites of de novo forming non-centrosomal MTs, while it is absent from the centrosomes. In addition, we show
that HSPB1 binds preferentially to the lattice of newly formed MTs in vitro, suggesting that its function occurs by stabilizing
MT seeds. Our findings open new avenues for the understanding of the role of HSPB1 in the development, maintenance and
protection of cells with specialized non-centrosomal MT arrays.
Citation: Almeida-Souza L, Asselbergh B, De Winter V, Goethals S, Timmerman V, et al. (2013) HSPB1 Facilitates the Formation of Non-Centrosomal
Microtubules. PLoS ONE 8(6): e66541. doi:10.1371/journal.pone.0066541
Editor: Yanmin Yang, Stanford University School of Medicine, United States of America
Received February 20, 2013; Accepted May 7, 2013; Published June 24, 2013
Copyright:  2013 Almeida-Souza et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by the special research fund and the Methusalem program of the University of Antwerp, the Fund for Scientific
Research (FWO-Flanders), the Medical Foundation Queen Elisabeth (GSKE), the ‘‘Association Belge contre les Maladies Neuromusculaires’’ (ABMM), the American
Muscular Dystrophy Association (MDA). We thank the Hercules foundation providing funding for the transmission electron and spinning disk microscopes. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: vincent.timmerman@molgen.vib-ua.be (VT); sophie.janssens@dmbr.vib-ugent.be (SJ)
¤ Current address: MRC Laboratory of Molecular Biology, Hills Road, Cambridge, United Kingdom
. These authors contributed equally to this work.
Introduction
The small heat shock protein HSPB1 (also known as HSP27) is
a ubiquitously expressed molecular chaperone that besides its
canonical folding function is involved in a wide range of cellular
processes such as apoptosis, actin cytoskeleton regulation and cell
proliferation [1]. Due to its multifunctional character, HSPB1 was
shown to play a role in several human disorders including cancer,
Alzheimer’s and heart disease [2]. In 2004 we found that
mutations in HSPB1 cause a peripheral neuropathy called
Charcot-Marie-Tooth disease (CMT) [3].
Previously we discovered that a subset of these CMT causing
HSPB1 mutations leads to higher chaperone activity [4] and an
increased binding of HSPB1 to tubulin and MTs [5]. This
enhanced binding stabilizes the MT network in a similar fashion to
what is described for other microtubule associated proteins (MAPs)
[6]. Interestingly, we found that wild-type HSPB1 also binds
tubulin and MTs, which confirms earlier data [7,8]. However, the
functional relevance of this binding has never been addressed.
Here, we show that HSPB1 regulates the architecture of the
cellular MT network by facilitating the formation of non-
centrosomal MTs.
Materials and Methods
Cell Culture, Constructs and Recombinant Protein
Production
Stable HeLa and CHO cell lines were produced by lentiviral
transduction according to the method described in [9]. Cells with
HSPB1 overexpression were produced with constructs containing
V5 tagged HSPB1 using the constructs described elsewhere [4].
HeLa cells with HSPB1 knock down were generated by lentiviral
transduction of shRNA constructs (Sigma). Stable cell lines were
discarded and freshly generated after 15–25 passages to ensure
optimal expression and silencing of HSPB1. Most experiments
were repeated using stable cell lines generated independently.
TUBB3-GFP and EB1-GFP constructs were generated using
Gateway recombination (Invitrogen). For recombinant protein
production, the ORF from HSPB1 was amplified by PCR and
cloned by topoisomerase cloning into the vector pCRT7-NT-
TOPO (Invitrogen). Protein expression was induced in BL21 DE3
cells and proteins were purified on a Ni-NTA column followed by
a size exclusion purification step in an S200 column. DCX was
purchased from Origene.
Nocodazole Washout Experiments
Cells were seeded in 24-well plates containing coverslips and
treated 48 h later with 10 mm nocodazole for 6 h. After treatment,
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cells were washed once with cold PBS and fresh, pre-warmed
media was added and cells were allowed to recover for different
periods. After the recovery period, media was removed and
unpolymerized tubulin was washed away by detergent extraction
(BRB80 containing 0.5% Triton X-100 for 30 s). For colocaliza-
tion experiments that include HSPB1 staining, we omitted the
detergent extraction step because it removes all HSPB1 from the
cells. Cells were then fixed with 3% paraformaldehyde (PFA) and
stained with the indicated antibodies by standard immunocyto-
chemical procedures. Following primary antibodies were used:
Mouse monoclonal anti-a-tubulin (Abcam), Mouse monoclonal
anti-a-tubulin conjugated with dyomics-547 (Abcam), Mouse
monoclonal anti-HSPB1 (Enzo Life Sciences), Goat polyclonal
anti-HSPB1 (Santa Cruz biotechnology), Mouse monoclonal anti-
acetylated-tubulin (Santa Cruz biotechnology), Rabbit polyclonal
anti-Giantin (Abcam). When a-tubulin and acetylated tubulin
were co-stained (as in Fig. 1F), the mouse anti-acetylated-tubulin
antibody and corresponding secondary antibody was used prior to
staining with the directly conjugated mouse anti-a-tubulin
antibody to avoid cross-reactivity.
Confocal image stacks were taken with a Zeiss LSM700
confocal laser scanning microscope equipped with a 63X 1.4
NA objective and 405, 488, 555 and 639 nm diode lasers.
Standard excitation and emission settings were used to detect and
discriminate the different fluorophores. When different experi-
mental conditions were compared, identical acquisition parame-
ters were used for all conditions.
If indicated, image hyperstacks (xyzt) were deconvolved using
the ImageJ Iterative Deconvolve 3D plugin with theoretically
calculated point spread functions, created with the Diffraction PSF
CD plugin (Copyright (c) 2005, OptiNav, Inc., http://www.
optinav.com/Iterative-Deconvolve-3D.htm and http://www.
optinav.com/Diffraction-PSF-3D.htm).
For measurement of total MT length and number of MTs in
HeLa cells, images were initially processed with the Tubeness plugin
of the open source image analysis platform ImageJ [10]. This filter
recognizes tubular structures and was used to improve the
sharpness of MTs and to remove the central part of centrosomes
(as they are not recognized as tubular structures), facilitating the
counting. We then applied the skeletonize filter to transform MTs
in single pixel lines and the number and size of MTs was
determined using the ImageJ 3D Object Counter plugin. The
segmentation results were manually verified and a size threshold
was determined for each image to remove from the analysis
overlapping MTs that were erroneously considered as single MTs.
De novo non-centrosomal formed MTs in HeLa cells were
counted manually. Only MTs without any sign of tubulin
acetylation were considered a truly de novo formed MT. Counting
of cells with clear MT asters in HeLa cells was performed by
manual scoring. Three independent groups of at least 100 cells
were counted per coverslip. The size of MT asters in CHO cells
were determined by manually selecting the MT asters and
measuring its size in ImageJ.
Live Cell Imaging
CHO cells were cultivated in 35 mm glass-bottom dishes and
transfected with a EB1-GFP construct [5] using lipofectamine
LTX (Invitrogen). Cells were imaged 72 h after transfection using
using an UltraVIEW VoX microlens-enhanced dual spinning disk
(Yokogawa CSU-X1) system (PerkinElmer), installed on a Nikon
Ti inverted microscope equipped with a C9100-50 EMCCD
camera (Hamamatsu) and controlled by Volocity software
(PerkinElmer). For EGFP discrimination, 488 nm diode laser
excitation and standard fluorescence filters were used in combi-
nation with a 60X 1.4 NA plan apochromatic objective. The
Nikon Perfect Focus System (‘‘PFS’’) was used to automatically
maintain the microscope focus. During imaging, cells were
maintained at 37uC and 5% CO2.
For live observation of MT repolymerization, cells were treated
with nocodazole for 6 h, placed in the microscope and washed
three times with 5 ml of media while imaging. Multi-plane image
z-stacks comprising the complete cell volume were acquired every
5 sec, with a total exposure time of the stack of less than 2 sec.
After acquisition, image stacks were exported as 16bit Tiff files and
further processed in ImageJ. To visualise the dynamics of the
entire 3D volumes in a single plane, maximum intensity
projections were created for every time point, which were then
combined into a single time sequence. As the duration of washings
varied between videos, we decided to set as time zero the moment
where the first EB1-GFP fluorescence bursts occurred. Non-
centrosomal EB1 comets were tracked using the ImageJ Manual
Tracking plugin. Only comets with unambiguous non-centrosomal
origin that could be clearly followed for more than three frames
were tracked.
For observation of EB1-GFP comets in steady state, image
acquisition and image processing was performed as described
above, except for higher camera exposure times and smaller time
intervals: multi-plane images of cells were acquired for 2 min at a
3 sec/frame. To distinguish between centrosomal and non-
centrosomal MTs, we imaged only cells in which the centrosome
was localized between the nucleus and the glass substrate and
clearly distinguishable from the perinuclear Golgi area. EB1
comets were tracked using the ImageJ Manual Tracking plugin. To
ensure that only bona fide centrosomal and non-centrosomal EB1
comets were shown, we ignored comets with ambiguous/unknown
origin or that could not be individualized from other tracks.
MT Distribution Measurement
To evaluate the relative distribution of tubulin over the center
and the cell periphery, a customized image analysis procedure was
generated in ImageJ to measure pixel intensities near the cell
center and near the cell periphery. Two regions of interest were
manually selected for each cell: i) a central point, inside the region
with highest tubulin concentration and located centrally in the cell,
was identified as a point selection; and ii) the borders of the cell
were outlined with a polygon selection. Next, the ImageJ macro
uses the coordinates of these regions of interest to generate a
number of straight line profiles, starting at the central point and
ending at the cell border. The lines, which will differ in length, are
created for different angles with a fixed angle interval and together
comprise the full 360u rotation. In the results that are presented,
120 lines are drawn with an angle interval of 3u. For each of the
line profiles two parameters are measured: i) the mean pixel
intensity in the inner part of the line (closest to the central part of
the cell; in the presented data defined as the inner 10% of the line
length), and the mean pixel intensity of the outer part of the line
(near the cell periphery; defined in the presented data as the outer
40% of the line length). The ratio (R) between the inner (Ii) and the
outer (Io) mean intensities is then calculated for each line and the
microtubule distribution index (MDI) is represented by the
average of all R’s for each cell. The MDI is a parameter that
correlates with the tubulin distribution in the cell: a low ratio
represents a predominantly centralized MT network, whereas a
higher ratio corresponds to a more spread out distribution of the
MT network. Variations in the measurement procedure were
tested, such as using different angle intervals, taking larger or
smaller inner and outer line lengths or measuring maximum
instead of mean pixel intensities. These changes in settings resulted
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Figure 1. HSPB1 facilitates the formation of non-centrosomal microtubules in HeLa cells. (A) Western blot using a polyclonal anti-HSPB1
antibody showing different HSPB1 expression levels in HeLa and CHO cells before and after nocodazole treatment. These were obtained by using
either non-transduced cells (called naive Hela and CHO HSPB1-), cells transduced with HSPB1-V5 (called HeLa HSPB1+ and CHO HSPB1+) or cells
transduced with shRNA HSPB1 constructs (called HeLa HSPB1-). End HSPB1= endogenous HSPB1. (B) Fluorescence quantification of HSPB1
expression using anti-V5 and anti-HSPB1 antibodies in different HeLa and CHO stable cell lines (V5/HSPB1 staining n= 33/56, 63/58, 36/48, 50/41, 32/
53 for CHO HSPB1-, CHO HSPB1+, HeLa HSPB12, Naive HeLa and HeLa HSPB1+, respectively). (C) Representative images from HeLa HSPB1+ and HeLa
HSPB1- cells at 1 min after nocodazole washout. The white arrow indicates a MT aster that is present predominantly in HeLa HSPB1- cells. (D)
Quantification of the percentage of cells containing a MT aster at different time points after nocodazole treatment (data from 3 independent
experiments of at least 100 cells). (E) The MT distribution at 5 min after nocodazole washout showing a different repolymerization pattern between
cells with different HSPB1 levels. (F) Quantification of the length and amount of total MTs cells expressing different amounts of HSPB1 at 5 min after
HSPB1 and Non-Centrosomal MT Formation
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in similar outcomes for the output ratios, hence, these were chosen
somewhat arbitrarily for the presented data.
The measurements were performed on maximum intensity
projections of confocal z-stacks, acquired in a Zeiss LSM700
confocal microscope equipped with a 63X 1.4 NA objective with
identical acquisition parameters for both genotypes. In total, the
measurements were performed on over 200 cells for each
genotype, originating from three independent tubulin stainings.
Microtubule Dynamics Measurements
HeLa cells with different HSPB1 levels were cultivated in
35 mm glass-bottom dishes and transfected with the TUBB3-GFP
constructs using Lipofectamine LTX (Invitrogen). Cells were
imaged 72 h after transfection for 2 min at 3 sec per frame for
TUBB3-GFP-transfected cells on a Zeiss Axiovert 200 microscope
with a microlens-enhanced dual spinning disc confocal system
(UltraVIEW ERS; PerkinElmer), equipped with a 63X 1.4NA
objective. During imaging, cells were maintained at 37uC and 5%
CO2. Individual TUBB3-GFP MTs were tracked manually using
the Manual Tracking plugin of ImageJ and dynamics parameters
were extracted from the data by a custom-made Perl script. The
MTs were considered static if they moved less than 0.3 mm per
frame.
MT Cosedimentation Assay
The binding of HSPB1 to MTs was assessed by polymerizing
37.5 mM pure tubulin (Cytoskeleton Inc) in the presence of 10 mM
HSPB1 or 10 mM GFP in BRB80 (80 mM PIPES, 1 mM MgCl2,
1 mM EDTA), supplemented with 1 mM GTP for 30 min. After
polymerization, reactions were centrifuged at 100.000 g for
30 min at 35uC. Supernatant was then transferred to another
tube, the pellet was washed with BRB80 buffer and resuspended in
the same volume as the supernatant.
In vitro Microtubule Polymerization Assays
Microtubule assembly was monitored by DAPI fluorescence
according to the protocol described elsewhere [11]. Polymeriza-
tion was performed using MAP-rich tubulin (Cytoskeleton Inc -
Cat. # ML113) in BRB80 buffer and 1 mM GTP and 10 mM
DAPI (final concentrations) and recombinant HSPB1 at 5 mM
when stated. The fluorescence of MT-bound DAPI was monitored
with a BioTek plate reader each 30 sec with the temperature set to
37uC. The excitation and emission wavelengths were set at 360
and 450 nm, respectively.
In vitro MT Nucleation Assay
A solution in BRB80 (80 mM PIPES, 1 mM MgCl2, 1 mM
EDTA) of 8 mm tubulin at a 1:10 ratio of TRITC-rhodamine
tubulin:unlabeled tubulin (MAP-rich tubulin - Cytoskeleton Inc)
supplemented with 1 mM GTP with different concentrations of
HSPB1 and DCX were incubated at 37uC for 5 min, fixed for
3 min with 1% glutaraldehyde in BRB80, diluted 100x in BRB80
and spotted onto coverslips. Images (102461024 pixels, 0.1 mm/
pixel) were acquired with a Zeiss LSM700 confocal microscope
equipped with a 63X 1.4 NA objective. Number and size of MTs
were measured by using the ImageJ Analyze Particles function after
intensity thresholding with a fixed minimum. At least 25 random
image fields on the coverslip were used.
Immuno-EM
10 mm tubulin (MAP-rich tubulin) together with 10 mm HSPB1
or EGFP were polymerized for 3 or 30 min in BRB80/GTP as
described above and reactions were stopped by adding glutaral-
dehyde at a 1% final concentration. The 3 min time point was
chosen for containing many short MTs that would resemble a
recently nucleated MT, while the 30 min time point contain
predominantly long MTs resembling mature MTs. Five ml of the
reaction was spotted on formvar carbon coated 200 Mesh EM
grids (Electron Microscopy Sciences). Grids were then incubated
for 10 min with anti-HSPB1 (Stressgen) or anti-GFP (Clontech)
antibodies, washed with 20 ml of BRB80 and incubated for an
additional 10 min with goat anti-mouse IgG labeled with 10 nm
gold (Aurion). Next, grids were stained with uranyl acetate and
visualized in a FEI tecnai G2 Spirit BioTWIN transmission
electron microscope (FEI Co) at a 26.5006magnification. The MT
length was measured using ImageJ and quantification of HSPB1
binding density to MTs was done by visual counting. For the
calculation of the correlation between MT-bound HSPB1 density
and MT length, a series of overlapping EM images (464 at
26.5006magnification) of MTs at the 3 min polymerization
condition were stitched together using the ImageJ plugin MosaicJ
[12]. MT length and MT-bound HSPB1 density was calculated as
above, using only MTs fully contained within the stitched image.
Correlation was calculated using Spearman’s correlation coeffi-
cient.
Statistical Analyses
Statistical significance for the different measurements was tested
using a two-tailed t-test.
Results
HSPB1 Favors the Formation of Non-centrosomal
Microtubules
While studying the role of CMT-causing HSPB1 mutants in
MT biology [5] we observed that HeLa cells overexpressing
HSPB1 (either mutant or wild-type forms) display a less prominent
MT aster when compared to their naive, untransfected counter-
parts during repolymerization of the MT network. To investigate
this observation in more detail we repeated these experiments
using stable HeLa cells expressing different levels of HSPB1 by
using either overexpression or knockdown of HSPB1 (hereafter
called HeLa HSPB1+ and HeLa HSPB1- cells, respectively)
(Fig. 1A and Fig. 1B). The MT network was depolymerized by
nocodazole treatment for 6 h and allowed to repolymerize for
short periods of time prior to fixation and analysis. In most
mammalian cells, MTs repolymerize by eradiating from the
centrosome in a distinct aster-like structure. However, at 1 min
after nocodazole washout, only a small fraction of the HeLa
HSPB1+ cells (,10%) displayed a distinct centrosomal MT aster
while most HeLa HSPB12 cells (,80%) showed a distinct
centrosomal MT aster (Fig. 1C). Naive HeLa cells, which only
express endogenous HSPB1, exhibited an intermediate phenotype
with distinct MT asters in about 40% of cells. At later stages of
repolymerization, the number of cells presenting clear asters
increased steadily for all conditions until all cells showed clear
asters at 5 min after nocodazole washout (Fig. 1D).
nocodazole treatment (n = 24, 20, 20 cells for HSPB1+, Naive Hela and HSPB1-, respectively). (G) Representative images of HeLa HSPB1- and HeLa
HSPB1+ stained for a- and acetyl-tubulin. For the quantifications shown in the graph, only MTs not showing acetylated regions were counted (n = 49,
64, 58 cells for HSPB1+, Naive Hela and HSPB12 respectively). In F and G, all averages are different from each other with p.0.05, with the exception
of total MT number between HeLa HSPB1+ and Naive HeLa (p = 0.09). Data is presented as average 6 SEM. Scale bars = 5 mm.
doi:10.1371/journal.pone.0066541.g001
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In addition to the effect on the MT aster, we observed that
HeLa HSPB1+ cells displayed a large number of small isolated
non-centrosomal MTs spread in all regions of the cytoplasm at
5 min post-nocodazole washout, while HeLa HSPB1- cells
presented fewer and longer MTs eradiating mostly from the
centrosomal area. Again, naive HeLa cells showed an intermediate
phenotype (Fig. 1E). Quantification of length and number of total
MTs showed that the number of MTs was positively related to the
expression level of HSPB1, while MT length presented an inverse
trend (Fig. 1F).
During these experiments we observed that in many cells, even
after 6 h of nocodazole treatment, a few short MTs remain intact,
which could consequently also serve as templates for repolymer-
ization after nocodazole washout. To correctly identify and
quantify only de novo formed non-centrosomal MTs, we included
an additional co-staining for acetyl-tubulin to discriminate MTs
that were unaffected by the depolymerization treatment. Imme-
diately after nocodazole washout, all resident MTs were
completely acetylated and did not differ in number, length nor
distribution between HeLa HSPB1+ and HeLa HSPB12 cells
(Fig. S1). During repolymerization, the number of de novo formed
non-centrosomal MTs, i.e. MTs not harboring an acetylated tail,
correlated to HSPB1 levels (Fig. 1G). Interestingly, cells expressing
the CMT causing HSPB1 mutant S135F, which is hyperactive [4]
and stabilizes mature MTs [5] displayed the same amount of de
novo non-centrosomal MTs and showed a similar, less prominent
aster formation as cells expressing wild-type HSPB1 (HSPB1+)
(Fig. S2). These results confirm that HSPB1 does not influence the
availability of nocodazole-resistant MT that serve as seeds for
polymerization, but increases the number of newly nucleated non-
centrosomal MTs. Furthermore, this function of HSPB1 is not
affected in hyperactive CMT causing mutants.
To confirm these results we performed the same assays
employing a different cell line (CHO). In contrast to HeLa cells,
CHO cells express low endogenous levels of HSPB1 [13,14].
Therefore, naive CHO cells (hereafter called CHO HSPB12)
have a comparable HSPB1 level to the HeLa cell with HSPB1
knockdown (HeLa HSPB12). In addition, we generated a stable
CHO cell line overexpressing HSPB1-V5 (Fig. 1A and Fig. 1B)
(hereafter called CHO HSPB1+). In line with the results shown for
HeLa, CHO HSPB1+ cells displayed a less prominent aster
(Fig. 2 A–C) accompanied by a larger number of non-centrosomal
MTs (Fig. 2B and Fig. S3) when compared to the CHO HSPB1-
cells. On the other hand, despite the difference in aster area, all
CHO cell lines displayed a clear aster at all the time points tested
(data not shown). This difference with the results in HeLa cells can
be explained by the observation that the asters from CHO cells do
not depolymerize completely, even after 6 hours of nocodazole
treatment (Fig. S4).
As an additional confirmation of these results, we decided to
look at the MT repolymerization pattern in these cells in real time.
To this end, we transfected cells with the MT +TIP protein EB1-
GFP, treated them with nocodazole and imaged MT repolymer-
ization during and after nocodazole washout by time-lapse
microscopy. Non-centrosomal MT formation sites could be
identified by the formation of fluorescence bursts followed by the
formation of a typical EB1-GFP comet with direction and origin
clearly distinct from those coming from the centrosome [15]. In
line with our previous results, cells with high HSPB1 levels
displayed multiple MT formation sites after nocodazole washout
while cells with low HSPB1 levels presented predominantly
centrosomal MTs (Fig. 2D and Movie S1). The difference in the
formation of centrosomal MTs was also clear with CHO HSPB1+
cells showing less centrosomal originated EB1 comets compared to
CHO HSPB12 cells.
To check if these results are only due to the differences in
HSPB1 levels and not secondary effects, we measured protein
levels and the cellular distribution of tubulin, actin and c-tubulin
before and after nocodazole. As shown in Fig. 1A, S5 and S6 the
level and the cellular distribution of these proteins did not change
between cell lines before or after nocodazole treatment.
HSPB1 Accumulates at Non-centrosomal MT Formation
Sites but not at the Centrosome
To further understand the role of HSPB1 in the formation of
non-centrosomal MTs and in the growth delay of the MT aster,
we investigated the cellular localization of HSPB1 during MT
repolymerization after nocodazole treatment in naive HeLa.
Consistent with the role of HSPB1 in non-centrosomal MT
formation, at 1 min after nocodazole washout, we detected
HSPB1 accumulation at perinuclear regions containing high
tubulin concentration (Fig. 3A). Interestingly, these tubulin and
HSPB1 accumulations resembled in size and localization to the
EB1-GFP fluorescence bursts we observed during the live cell
imaging (Fig. 2D). Furthermore, these regions also colocalized
with the Golgi apparatus, which is a well-known site for non-
centrosomal MT formation [16,17]. Strikingly, while HSPB1
appeared to be present at non-centrosomal sites of MT nucleation,
we could not detect any accumulation of HSPB1 at the
centrosomes (Fig. 3A), suggesting an indirect influence of HSPB1
on the delay in growth of the MT aster.
Importantly, at 5 min after nocodazole washout, when the MT
network is in an advanced state of recovery and the MT formation
at the Golgi become less frequent, the accumulation of HSPB1 to
the Golgi was less prominent (Fig. 3B).
HSPB1 Levels Influence Non-centrosomal MT Formation
and the MT Network Architecture in Steady State Cells
So far, we have shown that high HSPB1 levels are able to
induce the formation of non-centrosomal MTs in cells upon
nocodazole treatment. To probe the physiological relevance of
these findings we decided to investigate whether HSPB1 also
influences MT formation in steady state cells by looking at MT
polymerization with EB1-GFP. Because MT rescue events are
extremely rare in the center of the cell [18], EB1 tracks originating
from central cellular areas can be considered novel nucleation
events [17]. Therefore, novel non-centrosomal MT formation
events can be identified as EB1 tracks originated from central
cellular areas distinct from the regions containing the centrosome.
EB1 tracks from cells with high HSPB1 levels showed a clear non-
centrosomal pattern, while cells with low HSPB1 levels showed
mostly centrosomal-originated tracks, suggesting that HSPB1
levels induce non-centrosomal formation also in steady state
(Fig. 4A, Fig. S7, Movies S2 and S3).
Since HSPB1 levels are able to affect the balance between
centrosomal and non-centrosomal MT formation, we hypothe-
sized that steady-state cells with high HSPB1 levels would present
a more even distribution of MTs throughout the cell, while cells
with low HSPB1 levels would present a more concentrated MT
distribution due to the predominance of centrosomal MTs. To
assess this, we developed an image analysis procedure that
measures the distribution of MTs in a cell by calculating the ratio
between fluorescence intensities near the centrosome and near the
cell periphery (Fig. 4B, see methods for more details). In
accordance with our previous results, cells with high levels of
HSPB1 displayed a more evenly spread MT network, when
HSPB1 and Non-Centrosomal MT Formation
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Figure 2. HSPB1 facilitates the formation of non-centrosomal microtubules in CHO cells. Representative images from CHO HSPB1- and
CHO HSPB1+ cells at (A) 3 min and (B) 5 min after nocodazole washout. Scale bar = 10 mm. For more examples, see Figure S3. (C) Quantification of the
aster area of CHO HSPB1+ and CHO HSPB1- cells at 3 and 5 min after nocodazole washout (n = 90/83 and 106/106 for CHO HSPB12/CHO HSPB1+ at 3
and 5 min respectively). Data is presented as average 6 SEM. (D) Time lapse microscopy of EB1-GFP during nocodazole washout and MT
polymerization in CHO HSPB12 and CHO HSPB1+ cells (see Movie S1). Image stacks comprising the complete cell volume were continuously
acquired every 5 sec before, during and after nocodazole removal by medium exchange. Maximum intensity projections of all stacks were made and
selected time points are shown with inverted grey scale. The appearance of the first EB1 fluorescence burst was set as time zero, which occurred
within 1 min after the initiation of the washout procedure (middle images). Before the start of nucleation (left image), only static, residual EB1-GFP
spots are visible. The images at the third column are maximum intensity projections (MIP) over time of 9 time points (45 sec) after nucleation.
Nucleation sites are marked by blue arrowheads. 3D image deconvolution was applied on the image stacks. Red arrows show the EB1-GFP non-
centrosomal comets tracked from nucleation sites. Green asterisk marks the centrosome. On the right side, MIP of the whole time sequence color-
coded for intensity. Scale bar = 5 mm.
doi:10.1371/journal.pone.0066541.g002
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compared to cells expressing low HSPB1 levels, which contained a
higher proportion of MTs originated from centrosomal regions
(Fig. 4C).
Next we also tested whether HSPB1 levels can affect other
aspects of MT biology in steady state cells. To this end, we
measured MT dynamics parameters using live cell imaging on
cells expressing TUBB3-GFP as described previously [5]. As
shown in Table S1, the level of HSPB1 had no influence on any of
the MT dynamics parameters measured (percentage of time at
pause, shrinking or growing states; speed of growth and shrinking;
and catastrophe and rescue frequencies). These results contrast our
earlier data that show effects of neuropathy causing HSPB1
mutations on MT dynamics [5] and shows that the function of
wild-type HSPB1 seems restricted to newly formed MTs.
HSPB1 Binds Preferentially to the Lattice of Newly
Polymerized MTs
To better understand the role of HSPB1 in MT formation we
decided to further study this function in vitro. First we checked if
the binding of HSPB1 to MTs is direct or mediated by other
Figure 3. HSPB1 colocalizes to non-centrosomal formation sites only at early stages of repolymerization. Naive HeLa cells stained for
HSPB1, a-tubulin and the Golgi apparatus marker Giantin at (A) 1 min and (B) 5 min after nocodazole washout. Graphs represent line intensity plots
for the lines drawn in the corresponding images. Note that HSPB1 does not colocalize with the centrosome (circled in yellow). 3D image
deconvolution was applied on the image stacks in (A–B). Scale bar = 5 mm.
doi:10.1371/journal.pone.0066541.g003
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Figure 4. HSPB1 changes the architecture of the MT network in steady state cells. (A) Live cell imaging of CHO cells expressing EB1-GFP
(Movie S2). Maximum intensity projections color-coded for time of 20 (center) and 10 (right) frames. (For more examples, see Fig. S7 and Movie S3).
Scale bar = 10 mm. (B) Graphical representation of the microtubule distribution index (MDI) method. After defining the cell boundaries and a central
intense point in the cell, a series of lines are drawn from the central point to the periphery. Mean intensities from the inner (Ii) and outer (Io) regions of
each drawn line were measured. The MDI for each cell is defined as the average Io/Ii ratio (R) for each line. (C) CHO cells with different HSPB1 levels
were stained with a-tubulin and their MDI was calculated (n =.200 cells from three independent stainings). Scale bar = 20 mm.
doi:10.1371/journal.pone.0066541.g004
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MAPs using pure tubulin in an in vitro MT cosedimentation assay.
Tubulin was polymerized in the presence of HSPB1 or the
negative control GFP and separated by centrifugation in a MT
and a soluble protein fraction. Reactions without tubulin were also
used as controls. Confirming that HSPB1 binds directly to MTs,
HSPB1 sedimented predominantly in the reaction with MTs
(Fig. 5A) while the negative control GFP remained in the soluble
fraction for all conditions (Fig. 5B). Next, we checked whether
HSPB1 is also able to influence the formation of MTs in vitro. MT
polymerization was monitored over time using low tubulin
concentrations, which disfavors spontaneous nucleation. At a
concentration of 8 mM of tubulin, the addition of HSPB1 resulted
in significantly more polymerization compared to the condition
with tubulin alone. At 6 mM of tubulin, polymerization could only
be measured in the reaction containing HSPB1, and was
completely absent when HSPB1 was not present (Fig. 5C). To
further confirm this finding, we performed an in vitro nucleation
assay in which a low concentration of tubulin was polymerized to
MTs for 5 min in the presence of different amounts of HSPB1 and
then spotted on a coverslip to assess MT size, amount and overall
structure. MTs from all conditions were formed in a similar
dispersed pattern, without the formation of bundles or any aster-
like structures. Similarly to what we observed in cells, the presence
of HSPB1 resulted in a dose-dependent increase in number and
reduction in size of MTs (Fig. 5D). For comparison, we also
performed these reactions in the presence of doublecortin (DCX),
which was shown before to stabilize and nucleate MTs by lateral
binding [19,20].
We then examined the binding of HSPB1 to MTs by immuno-
electron microscopy. To mimic newly formed and mature MTs we
polymerized tubulin for a short (3 min) and a long (30 min) period
of time before fixation and HSPB1 immunogold staining. As
shown in Figure 5E, HSPB1 binds laterally to MTs, similar to
what was described for other MAPs [19,21]. The negative control,
using the same conditions and recombinant GFP and an anti-GFP
antibody instead, showed little binding to MTs (Fig. S8). In
accordance with its exclusive role in newly formed MTs, the
density of MT-bound HSPB1 was higher in the condition
containing MTs at their initial stage of polymerization (3 min)
(Fig. 5E and Fig. 5F). To confirm that the higher binding density
of HSPB1 at 3 min does not result from a lower HSPB1:MT ratio
in the 30 min reaction, which has more MTs due to extended
polymerization time, we plotted the density of MT-bound HSPB1
over the size of MTs within the same reaction (3 min). Confirming
our previous result, we found a strong correlation between the
density of MT-bound HSPB1 and the length of MTs, with shorter
MTs containing a significantly higher density of bound HSPB1
when compared to long mature MTs (Fig. 5G). Taken together,
these results show that HSPB1 interacts directly with MTs by
lateral binding to the MT lattice, especially in the first stages of
MT formation.
Discussion
Microtubules are cytoskeletal structures characterized by a
dynamic behavior consisting of cycles of nucleation, growing and
shrinking. The precise spatial and temporal regulation of these
cycles is essential for the numerous cellular functions in which
MTs are involved. A large number of proteins are capable of
regulating this behavior [22–24]. Here we add the small heat
shock protein HSPB1 to the list of factors regulating the complex
biology of MTs. Our results show that HSPB1 binds laterally to
newly formed non-centrosomal MTs and facilitates their forma-
tion. This increase in non-centrosomal MT formation is accom-
panied by a reduction in the growth of centrosomal MTs and as
such determines the overall architecture of the MT network in
steady state cells.
How does HSPB1 assist the formation of MTs? Microtubule
nucleation is a complex process in which c-tubulin, assisted by a
large number of accessory proteins, forms a template to which
additional tubulin dimers can be sequentially added [25]. These
initial polymerized tubulin dimers form an unstable MT seed that
must be stable enough to successfully become a mature MT [25].
Our results show that HSPB1 binds preferentially to the lattice of
small MTs and, in cells, it concentrates at regions of non-
centrosomal nucleation such as the Golgi apparatus [16,17]. We
hypothesize that HSPB1 may be able to either locally increase the
concentration of active tubulin necessary for nucleation or
recognize and bind unstable lateral protofilament interactions of
newly-formed MTs. In either case, HSPB1 would shift the
equilibrium towards further polymerization, as opposed to
depolymerization, and as such would increase the probability of
successful de novo MT formation. The fact that HSPB1 binds to
MT in vitro but cannot be detected after cytosolic extraction
suggests that this interaction is weak or that the interaction in vivo is
very transiently. In addition, HSPB1 could also cooperate with
chaperonins and tubulin folding cofactors (TBCs) [26] by helping
to activate or stabilize tubulin dimers or other nucleation factors in
newly-formed MTs at non-centrosomal sites.
The Golgi apparatus is the most studied non-centrosomal
nucleation site in mammalian cells [16,17,27–29], however other
cellular sites were also described to serve as MT nucleation sites
such as the nuclear envelope [30] or the plasma membrane
[31,32]. One of the commonalities between all these non-
centrosomal nucleation sites is the requirement of c-tubulin for
their function [17,30,31]. The wide distribution of MTs formed
after nocodazole washout that we observed suggests that not all
HSPB1-induced non-centrosomal MTs nucleate from Golgi
vesicles, which is confirmed by the fact that only about half of
non-centrosomal MTs formed after nocodazole washout were
bound to Giantin (data not shown). Still, the phenotype we see in
our cells with low HSPB1 levels is remarkably similar to the
phenotype of cells depleted with other proteins involved in Golgi-
bound MT formation such as CLASP [17], AKAP450 and
GM130 [28]. An important question for the future is trying to
understand if (and how) these proteins cooperate spatio-temporally
to form Golgi-derived MTs.
Besides the HSPB1 function in promoting non-centrosomal MT
formation, we also observed that cells with high HSPB1 levels
displayed a delayed appearance (in HeLa cells) and reduced
growth (in HeLa and CHO cells) of centrosomal MTs. We could
not detect any accumulation of HSPB1 at centrosomes, pointing to
an indirect negative effect of this protein on MT growth at the
centrosome. One plausible explanation is that the large number of
non-centrosomal formation sites outcompetes the centrosome for
free tubulin, which delays its growth. Alternatively, HSPB1 could
also be modulating the levels of other proteins responsible for
regulating the growth of centrosomal MTs. The role of HSPB1
controlling the level of other proteins is extensively described in
literature [33–36].
The role of HSPB1 as a regulator of the actin cytoskeleton has
been studied for many years. Initially, HSPB1 was proposed to cap
actin filaments and inhibit their polymerization [37–39]. However,
further work showed that HSPB1 is able to bind to short actin
filaments generated after cellular stress in order to avoid their
aggregation [40,41] and to participate in actin filament assembly
by shuttling actin monomers in a phospho-dependent manner
[42]. In addition, CMT causing mutations in HSPB1 were shown
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Figure 5. HSPB1 facilitates the formation of MTs in vitro and binds to MTs at early stages of their polymerization. (A–B) Coomassie
staining of MT cosedimentation assays. Pure tubulin was polymerized in the presence of (A) HSPB1 or (B) GFP for 30 min and fractionated into MT
and soluble proteins fraction. Control reactions without tubulin were also used. S = soluble fraction, M=Microtubule fraction. (C) MTs were
polymerized from 8 mM or 6 mM MAP-rich tubulin with or without 5 mM HSPB1. MT assembly was monitored by DAPI fluorescence. (D) MT in vitro
nucleation assay. 8 mM of a 1:10 mixture of rhodamine-labeled tubulin and MAP-rich tubulin was polymerized alone or in the presence of different
concentrations of recombinant HSPB1 and doublecortin (DCX) for 5 min and spotted onto coverslips. Images from 25 random fields were used to
assess number and size of microtubules. All measurements are statistically significant (p,0.01) from each other with the exception of tub:HSPB1(1:2)
and tub:DCX for MT size; and tub:HSPB1(1:0.5) and tub:DCX for MT number. Scale bar = 20 mm. (E) MTs were polymerized from MAP-rich tubulin in
the presence of HSPB1 for 3 and 30 min and visualized by TEM after immunogold staining using an anti-HSPB1 antibody. Scale bar = 50 nm. (E) MTs
were polymerized from MAP-rich tubulin in the presence of HSPB1 for 3 and 30 min and visualized by TEM after immunogold staining using an anti-
HSPB1 antibody. Scale bar = 50 nm. (F) Quantification of the density of MT-bound gold particles (HSPB1) (n = 105 MTs for 3 min and 110 MTs for
30 min). (G) Scatter plot showing the relationship between MT-bound HSPB1 density and MT length (n = 128 MTs) on MTs polymerized for 3 min.
These two parameters showed significant negative correlation (Spearman correlation coefficient =20.614, p,0.01). Data are presented as average 6
SEM. ***p,0.001.
doi:10.1371/journal.pone.0066541.g005
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to interfere with the assembly of the neurofilament network [3],
suggesting that wild-type HSPB1 may also have a role in the
biology of this cytoskeletal structure. Taking into account the
results presented in this manuscript, HSPB1 emerges as an
important player in the regulation of the cytoskeleton as a whole.
Moreover, HSPB1 is present in complexes containing other small
heat shock proteins (sHSPs) [43,44], some of which are also
capable to regulate cytoskeletal structures [45]. Understanding
how HSPB1, and its sHSPs partners, are regulated and how they
cooperate to control all these aspects of cytoskeletal biology will be
a great challenge for future research.
We previously showed that peripheral neuropathy causing
HSPB1 mutants are hyperactive and bind more strongly to MTs
causing their stabilization [5]. In contrast, the hyperactivation of
these mutants does not increase their MT formation properties
(Fig. S2). Therefore we hypothesize that the MT stabilization
property of these mutants is the result of a misregulation of the
MT formation activity of wild-type HSPB1. Due to their increased
affinity for MTs, we believe that hyperactive mutants remain
bound to mature MTs rather than being released after their
maturation. This shift in equilibrium between binding and release
turns the hyperactive mutants into MAP-like molecules. A
graphical representation of this model is presented in Fig. S9.
Our results show that steady state cells with high HSPB1 levels
display a more non-centrosomal MT network. In contrast to
plants, non-centrosomal MT formation is relatively uncommon in
interphasic mammalian cells, but does occur in highly specialized
cells, such as neurons, myocytes and epithelial cells [46]
Interestingly, these cells constitutively express high levels of
HSPB1 [47–49] and the knockdown of this protein was shown
to be detrimental for their differentiation [49–51]. Therefore, it is
tempting to speculate that in vivo the high levels of HSPB1 may
play a role in the formation and maintenance of non-centrosomal
MT arrays in these cells. Furthermore, HSPB1 is a known
protective factor in heart ischemia [52] and in neurodegeneration
[53]. Since the maintenance of the MT network is pivotal in the
ability of these cells to recover from insults [54–56], we believe that
the protection rendered by HSPB1 in these tissues could also be
based on its capacity to maintain a functional MT network by
facilitating MT formation.
In conclusion, our results unravel a novel function of HSPB1 on
non-centrosomal MT formation, which brings new mechanistic
insights into the ill-understood biology of mammalian non-
centrosomal MT arrays and in the role of this chaperone in
human diseases.
Supporting Information
Figure S1 Remaining acetylated MTs after nocodazole
treatment. (A) Representative images of HeLa HSPB1+ and
HeLa HSPB1- cells 6 h after nocodazole treatment, immediately
(without any repolymerization time) fixed and stained for a- and
acetyl-tubulin. (B) Quantification of number and size of acetylated
MTs from HSPB1+ and HSPB1- after nocodazole washout
showed that there is no difference in remaining polymerization
‘‘seeds’’ between the different cell lines immediately upon
depolymerization (n = 105 HeLa HSPB1+ cells and 110 HeLa
HSPB1- cells). Data are presented as average 6 SEM. Scale
bar = 5 mm.
(TIF)
Figure S2 CMT causing HSPB1 mutants induce the
formation of de novo MTs to the same extent as wild-
type HSPB1. Representative image and quantification of de novo
non-centrosomal MTs in HeLa cells expressing the S135F mutant.
Cells were stained for a- and acetyl-tubulin. HeLa HSPB1 S135F
cells presented a similar repolymerization phenotype as HeLa
HSPB1+ cells (n = 41 cells for HeLa HSPB1 S135F). Data is
presented as average 6 SEM. Scale bar = 5 mm.
(TIF)
Figure S3 MT repolymerization pattern of CHO cells.
Additional pictures from CHO HSPB1- and CHO HSPB1+ cells
at 5 min after nocodazole washout. Note the large difference in
aster size and number of non-centrosomal MTs between HSPB12
and HSPB1+ transfected CHO cells. Scale bar = 10 mm.
(TIF)
Figure S4 Centrosomal asters are extremely stable in
CHO cells after nocodazole treatment. CHO cells after 6 h
of nocodazole treatment (no recovery time) were stained for a- and
c-tubulin. Despite the extended nocodazole treatment, MT asters
in these cells remained intact. Scale bar = 10 mm.
(TIF)
Figure S5 HSPB1 levels and nocodazole treatment does
not affect the expression and the architecture of the
actin cytoskeleton. (A) Western blot showing the expression of
tubulin, actin and c-tubulin in HeLa and CHO stable cell lines
before and after nocodazole treatment. (B) Images of HeLa and
CHO stables before nocodazole treatment stained for a-tubulin
and F-actin (Phalloidin). (C) Nocodazole treatment depolymerizes
MTs without affecting the F-actin network. We detected no
differences in distribution or intensity of F-actin between cells lines
or treatments. Scale bar = 10 mm.
(TIF)
Figure S6 HSPB1 expression levels do not change the
distribution of c-tubulin in cells. Images of HeLa and CHO
stables 0 min after nocodazole treatment stained for a-tubulin and
c-tubulin. We detected no differences in distribution or intensity of
these stainings between cells lines or treatments. Note that CHO
cells have a more pronounced accumulation of c-tubulin at the
centrosome compared to HeLa cells. Scale bar = 10 mm.
(TIF)
Figure S7 MT architecture at steady state in CHO cells
expressing EB1-GFP. Additional pictures of live cell imaging of
CHO cells expressing EB1-GFP at time zero and maximum
intensity projections of 20 frames (1 min). Note that CHO
HSPB1- cells present a centrosomal polymerization pattern, as
reflected by the highly concentrated and symmetrical, centroso-
mal-originating EB1-GFP tracks; while the pattern in CHO
HSPB1+ cells is non-centrosomal, as reflected by the presence of
dispersed EB1-GFP tracks originated from multiple non-centro-
somal nucleation sites. These cells are also shown in Movie S3.
Scale bar = 10 mm.
(TIF)
Figure S8 GFP does not bind to polymerized MTs. TEM
micrograph from MTs polymerized in the presence of the negative
control GFP. The density of MT-bound GFP was also quantified
(0.17+/20.27 GFPs/MT mm, n=37 MTs, p,0.0001 in com-
parison with HSPB1). Scale bar = 200 nm.
(TIF)
Figure S9 Integrated model for HSPB1 microtubule
nucleation function and CMT pathogenesis. During the
formation of MTs, both WT and mutant HSPB1 bind to MTs
enhancing their stability and their success rate of becoming a
stable MT seed. When MTs reach a stable state, WT HSPB1
releases from the MTs and returns to its inactive, low affinity state.
However, due to its increased binding capacity, the binding
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equilibrium of mutant HSPB1 has shifted and the protein remains
bound to the MTs, leading to their enhanced stability.
(TIF)
Movie S1 MT repolymerization in CHO cells. CHO
HSPB12 (top) and CHO HSPB1+ (bottom) were transfected with
EB1-GFP, treated with nocodazole and washed while imaging
with spinning disk confocal microscopy. Image z-stacks comprising
the complete volume of the cells were acquired every 5 sec. The
movie shows the maximum intensity projections of all slices in the
z-stack with inverted grey scale. Images on the right are shown
with overlayed EB1-GFP tracks. Note the large difference in the
number of non-centrosomal and centrosomal MTs between cells.
(AVI)
Movie S2 EB1-GFP tracks in steady state cells. CHO
HSPB12 (top) and CHO HSPB1+ (bottom) were transfected with
EB1-GFP and imaged with spinning disk confocal microscopy.
Image z-stacks comprising the centrosomal and Golgi region were
acquired every 3 sec. The images on the left show the maximum
intensity projections of all slices in the z-stack with inverted grey
scale. Images on the right show these as cumulative maximum
intensity projections over the elapsed time. Note the large number
of non-centrosomal MTs formed in CHO-HSPB1+ cells.
(AVI)
Movie S3 Additional movies showing EB1-GFP tracks in
steady state cells. Same experimental setup as Movie S2. The
two top rows show HSPB12 cells while the two bottom rows show
HSPB1+ cells.
(AVI)
Table S1 HSPB1 levels do not interfere with MT dynamics in
steady state cells. TUBB3-GFP MTs were imaged at 3 s intervals
in naive HeLa cells or in cells overexpressing HSPB1 or with
HSPB1 knockdown transiently transfected with TUBB3-GFP. The
MTs life histories are represented as the percentage of time spent
in growth, shrinkage or pause phase. Catastrophe frequency is
given as the frequency that MTs transitioned from growth (or
pause) to shrinkage. Rescue frequency corresponds to the
frequency at which MTs transitioned from shrinkage (or pause)
to growth. Data are presented as average 6 SD. No significant
differences between the different cell lines were found.
(DOC)
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